Andlauer Healthcare Group Inc.
ANDHFOTCIndustrials
$38.11
+$0.00(+0.00%)
Market Cap$1.5B
P/E Ratio—
52W High$38.8495
52W Low$26.24
Andlauer Healthcare Group Inc. (ANDHF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANDHF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Jul 31, 2025EPS Actual
$0.25
Est. $0.31 · -20.4%
Revenue
$0.11B
Est. $0.17B · -30.5%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Jul 31, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
ANDHF reports quarterly as a OTC-listed Integrated Freight & Logistics company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 29, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 24, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 11, 2025 | — | — | — | — | $0.16B | — |
| ▼ Q3 FY2025 | Jul 31, 2025 | $0.31 | $0.25 | -20.4% | $0.11B | $0.17B | -30.5% |
| ▲ Q2 FY2025 | Apr 30, 2025 | $0.28 | $0.36 | +25.4% | $0.12B | $0.17B | -30.0% |
| ▼ Q1 FY2025 | Feb 26, 2025 | $0.32 | $0.30 | -4.8% | $0.12B | $0.17B | -31.6% |
| — Q4 FY2024 | Nov 5, 2024 | $0.30 | $0.30 | -0.8% | $0.12B | $0.17B | -31.0% |
| ▼ Q3 FY2024 | Jul 31, 2024 | $0.29 | $0.28 | -6.0% | $0.12B | $0.12B | -1.5% |
Q2 FY2026
Apr 29, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025Miss
EPS Actual
$0.25
EPS Est.
$0.31
EPS Surpr.
-20.4%
Revenue
$0.11B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$0.36
EPS Est.
$0.28
EPS Surpr.
+25.4%
Revenue
$0.12B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
$0.30
EPS Est.
$0.32
EPS Surpr.
-4.8%
Revenue
$0.12B
Q4 FY2024
Nov 5, 2024
EPS Actual
$0.30
EPS Est.
$0.30
EPS Surpr.
-0.8%
Revenue
$0.12B
Q3 FY2024
Jul 31, 2024Miss
EPS Actual
$0.28
EPS Est.
$0.29
EPS Surpr.
-6.0%
Revenue
$0.12B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.49 | $0.49 | $0.49 | 1 |
| Q3 FY2027 | $0.45 | $0.45 | $0.45 | 1 |
| Q2 FY2027 | $0.46 | $0.46 | $0.46 | 1 |
| Q1 FY2027 | $0.44 | $0.44 | $0.44 | 1 |
| Q4 FY2026 | $0.62 | $0.62 | $0.62 | 1 |
| Q3 FY2026 | $0.54 | $0.54 | $0.54 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Jul 31, 2025 | -20.4% | $38.11 | $38.11 | +0.00% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +25.4% | $38.30 | $38.30 | +0.00% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -4.8% | $32.53 | $32.53 | +0.00% |
| ▲ Q4 FY2024 | Nov 5, 2024 | -0.8% | $28.49 | $28.49 | +0.00% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -6.0% | $28.49 | $28.49 | +0.00% |
| ▼ Q2 FY2024 | May 2, 2024 | -19.7% | $37.80 | $37.80 | +0.00% |
| — Q1 FY2024 | Feb 29, 2024 | — | $37.80 | $37.80 | +0.00% |
| ▼ Q4 FY2023 | Nov 3, 2023 | -9.3% | No price data | $37.80 | — |
Q3 FY2025+0.00%
Report Date
Jul 31, 2025
EPS Beat/Miss
-20.4%
Price Before
$38.11
Price After
$38.11
Q2 FY2025+0.00%
Report Date
Apr 30, 2025
EPS Beat/Miss
+25.4%
Price Before
$38.30
Price After
$38.30
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
-4.8%
Price Before
$32.53
Price After
$32.53
Q4 FY2024+0.00%
Report Date
Nov 5, 2024
EPS Beat/Miss
-0.8%
Price Before
$28.49
Price After
$28.49
Q3 FY2024+0.00%
Report Date
Jul 31, 2024
EPS Beat/Miss
-6.0%
Price Before
$28.49
Price After
$28.49
Q2 FY2024+0.00%
Report Date
May 2, 2024
EPS Beat/Miss
-19.7%
Price Before
$37.80
Price After
$37.80
Q1 FY2024+0.00%
Report Date
Feb 29, 2024
EPS Beat/Miss
—
Price Before
$37.80
Price After
$37.80
Q4 FY2023—
Report Date
Nov 3, 2023
EPS Beat/Miss
-9.3%
Price Before
—
Price After
$37.80
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate2 / 8 quarters
Largest Move+0.00% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANDHF ends December
Andlauer Healthcare Group Inc. (ANDHF) most recently reported earnings on July 31, 2025 for Q3 FY2025, posting EPS of $0.25 — missing the analyst consensus of $0.31 by -20.4%. The next ANDHF earnings date is expected around September 1, 2026.
Each quarter, investors track ANDHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANDHF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANDHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANDHF earnings · 5 questionsAndlauer Healthcare Group Inc.'s next earnings report is expected around September 1, 2026. ANDHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANDHF historically reports after market close (AMC).
ANDHF earnings datewhen is ANDHF earningsANDHF next earnings datewhen does ANDHF report earningsANDHF earnings calendar
▸ Source: FMP · Andlauer Healthcare Group Inc. SEC filings · US GAAP · Andlauer Healthcare Group Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026